Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kangzhe Vision is a specialized ophthalmology subsidiary of China Medical System Holdings (CMS), focused on the development and commercialization of innovative ophthalmic therapies and devices. The company operates a comprehensive platform covering the entire value chain, including research and development, manufacturing, and a robust commercial network across China. Its portfolio includes a mix of marketed products and a deep pipeline targeting high-prevalence conditions such as age-related macular degeneration, dry eye disease, and myopia. By leveraging the extensive resources of its parent company, Kangzhe Vision aims to become a leading player in the Chinese ophthalmic market through strategic licensing and internal innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kangzhe Vision Technology.